MedPath

Hydration and Contrast-Induced Nephropathy in Primary Angioplasty

Phase 4
Completed
Conditions
Contrast Induced Nephropathy
Interventions
Drug: sodium bicarbonate solution
Drug: Isotonic saline
Drug: Placebo
Registration Number
NCT00770614
Lead Sponsor
Ospedale Misericordia e Dolce
Brief Summary

The purpose of this study is to determine whether hydration with sodium bicarbonate is more effective than hydration with sodium chloride to prevent contrast induced nephropathy in patients undergoing Primary Coronary Intervention for Acute ST Elevation Myocardial Infarction.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
450
Inclusion Criteria
  • patients with Acute ST Elevation Myocardial Infarction submitted to Primary Intervention
Exclusion Criteria
  • refusal to consent
  • previous contrast exposure within 72 hours

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1sodium bicarbonate solutionSodium Bicarbonate (154 mEq/L in dextrose and H2O) 3 mL/kg for 1 hour before contrast medium, followed by an infusion of 1 mL/kg/h for 12 hours after the procedure
2Isotonic salineIsotonic Saline (0.9% sodium chloride) 1 mL/kg/h for 12 hours after the procedure
3PlaceboPlacebo
Primary Outcome Measures
NameTimeMethod
Absolute increase of at least 0.5 mg/dl from the baseline value in serum creatinine concentration or a relative increase ≥ 25% over baseline serum creatinine within 5 days after contrast agent administrationwithin 5 days after contrast exposure
Secondary Outcome Measures
NameTimeMethod
Adverse clinical events within 1 month, including in-hospital death and need for dialysis or hemofiltration1 month

Trial Locations

Locations (1)

Ospedale Misericordia e Dolce

🇮🇹

Prato, Italy

© Copyright 2025. All Rights Reserved by MedPath